The Epilepsy Neurogenetics Initiative: Expertise for Challenging Cases

May 26, 2020 from 7:30 a.m. - 8:30 a.m. (ET)

It is estimated that genetic factors play a role in 50% of childhood-onset epilepsies and related neurodevelopmental disorders. Genetic testing, improved diagnostics and advancements in basic, translational and computational research offer clinicians new options for the diagnosis, treatment and ongoing management of children with difficult-to-treat or unexplained epilepsies.

This lecture will provide an overview of some of the pioneering work being done in CHOP’s Epilepsy NeuroGenetics Initiative (ENGIN) to discover new genetic causes of epilepsy, understand how these genetic variants can lead to seizures, and translate these discoveries into the development of individualized gene-specific treatments. 

Topics will include: 

  1. Overview of the genetic causes of childhood-onset epilepsies and related neurodevelopmental disorders 
  2. Update on basic neuroscience, translational, and computational research in the field of epilepsy genetics 
  3. Discussion on how current research and genetic testing informs management and clinical care of children with difficult-to-treat or unexplained epilepsies 

This webinar is complimentary and all participants will receive 1.0 Category 1 CME credit. 

Speakers include: Ethan Goldberg, MD, PhD and Katherine Helbig, MS, LCGC, Co-Directors of CHOP's ENGIN Initiative. 

Here is the link to join the webinar on May 26: 

Note: The BlueJeans webinar software works best on Google Chrome.

Contact: Shelly Norbury

(856) 397-5588



ACCME Accreditation Statement: Children’s Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement: Children's Hospital of Philadelphia designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Ethan M. Goldberg, MD, PhD and Katherine Helbig, MD. (Speakers), Katie Lockwood, MD (CHOP Talks Course Director), Zac Corrigan (Staff planner) Monica S. Williams (CME Planner) and others as appropriate have no relevant financial relationship with a commercial interest to disclose.